Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag in the page footer updated from v3.5.4 to v3.5.5, signaling a new site release version. This update is metadata-related and does not modify the study record content.
    Difference
    0.1%
    Check dated 2026-06-05T12:57:04.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new Revision tag v3.5.4 appears, replacing the previous revision tag v3.5.3 as part of the site's release notes.
    Difference
    0.1%
    Check dated 2026-05-15T03:17:43.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.3 instead of v3.5.2, indicating a new release/version of the ClinicalTrials.gov site. This update does not modify the study data or visible content on the page.
    Difference
    0.1%
    Check dated 2026-04-30T17:41:58.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the revision history.
    Difference
    0.1%
    Check dated 2026-04-16T10:47:30.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A new revision v3.5.0 was added and the previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:53.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The revision history now shows a new version entry (v3.4.3) and removes the previous entry (v3.4.2). This is a metadata update to the page's version history.
    Difference
    0.1%
    Check dated 2026-03-11T17:09:36.000Z thumbnail image

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.